December 2023 in “International Journal of Dermatology” This study observed that among transgender adults undergoing hormone therapy, common skin issues were acne, androgenetic alopecia, and other conditions, highlighting the need for dermatologists in their care; this is noted as the first Colombian and Latin American study on this topic.
21 citations
,
April 2019 in “Endocrinology and Metabolism Clinics of North America” This review discusses skin diseases in transgender patients receiving gender-affirming hormone therapy and procedures, highlighting unique conditions and the underdiagnosis that affects their quality of life and mental health.
1 citations
,
October 2022 in “Adolescent Health, Medicine and Therapeutics” This article discusses the dermatologic impacts of gender-affirming medical care in transgender adolescents and emphasizes the importance of patient-centered care to improve dermatologic and overall outcomes; it reports no new clinical results.
April 2021 in “Journal of Investigative Dermatology” This study found that transgender patients on masculinizing hormone therapy had a higher likelihood of developing acne compared to cisgender women, and were more likely to experience AGA compared to cisgender women.
December 2025 in “International Journal of Innovative Technologies in Social Science” This study systematically reviewed dermatological conditions affecting transgender and gender-diverse individuals, highlighting that testosterone therapy can induce acne in 25–88% of transgender men and alopecia after over two years, while dermatologic care must consider both medical and social complexities.